CSI Market
Sign In | Register

Fresh Tracks Therapeutics Inc (FRTX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access FRTX Annual Cash Flow →
Cash flow data covering Fresh Tracks Therapeutics Inc–Dec 31 2022 offers a view into how Dec 31 2023's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
12 Months 		(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Operating Activities
Income-5.69
Depreciation & amortization0.04
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.92
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Accretion Of Discounts On Short Term Investments-
Increase Decrease In Deferred Contract Costs-
Debt Securities Available for Sale Accretion Of Discount-
Liabilities Fair Value Adjustment-
Operating Lease Cost-
Amortization Of Debt Discount-
Increase Decrease In Operating Lease Liability-0.06
Issuance Of Stock Under License Agreement-
Issuance Of Common Stock To Settle Accrued Liabilities-
Increase Decrease In Prepaid Expense Contract With Customer Assets And Other Assets0.47
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-0.17
Increase (Decrease) in Accrued Liabilities-1.23
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.06
Discontinued operations0.00
Net Cash flow from Operating Activities-4.34
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock6.57
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.04
Principal Payments Under Equipment Financing Obligations-
Proceeds From Issuance Of Common Stock And Pre Funded Warrants-
Proceeds From The Issuance Of Employee Stock-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities6.53
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-4.34
Total Cash Flow2.19
4 historic quarters locked

Sign in to unlock the full Fresh Tracks Therapeutics Inc cash flow history.

Sign In Create Free Account

About Fresh Tracks Therapeutics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-24-011460

Figures are derived from filed reports and may be restated. Historical data is subject to revision.